Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04115059
Title Dasatinib In Waldenstrom Macroglobulinemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Jorge J. Castillo, MD
Indications

Waldenstroem's macroglobulinemia

Therapies

Dasatinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field